PNS229 COMPARATIVE ANALYSIS OF TRANSPARENCY COMMITTEE OPINION CONCERNING THE ADDED MEDICAL BENEFIT OBTAINED BY DRUGS AVAILABLE THROUGH EARLY ACCESS PROGRAM VS THE OTHERS
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.2129
https://www.valueinhealthjournal.com/article/S1098-3015(19)34507-3/fulltext
Title :
PNS229 COMPARATIVE ANALYSIS OF TRANSPARENCY COMMITTEE OPINION CONCERNING THE ADDED MEDICAL BENEFIT OBTAINED BY DRUGS AVAILABLE THROUGH EARLY ACCESS PROGRAM VS THE OTHERS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34507-3&doi=10.1016/j.jval.2019.09.2129
First page :
Section Title :
Open access? :
No
Section Order :
11848